{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:44:24Z","timestamp":1793504664199,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["20OK016"],"award-info":[{"award-number":["20OK016"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005039","name":"Leids Universitair Medisch Centrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005039","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xkme.2025.101200","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T03:23:16Z","timestamp":1765423396000},"page":"101200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Systematic Review and Meta-analysis of the Predictive Performance of Stroke and Bleeding Prediction Models in Atrial Fibrillation Patients With Kidney Disease"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-6864","authenticated-orcid":false,"given":"Liselotte F.S.","family":"Langenhuijsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle C.L.","family":"Derksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jet","family":"Milders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine F.B.","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel","family":"van Diepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge A.","family":"Trines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"den Exter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris I.","family":"Rotmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-1508","authenticated-orcid":false,"given":"Ype","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.xkme.2025.101200_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.xkme.2025.101200_bib2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/clc.23085","article-title":"Atrial fibrillation and chronic kidney disease: A review of options for therapeutic anticoagulation to reduce thromboembolism risk","volume":"41","author":"Bhatia","year":"2018","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.xkme.2025.101200_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266046","article-title":"Chronic kidney disease and atrial fibrillation: a dangerous combination","volume":"17","author":"Ocak","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib4","first-page":"126","article-title":"A review of risk factors for stroke in patients with chronic kidney disease","volume":"2","author":"Saeed","year":"2009","journal-title":"J Vasc Interv Neurol"},{"issue":"15","key":"10.1016\/j.xkme.2025.101200_bib5","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/eurheartj\/ehab059","article-title":"Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function","volume":"42","author":"de Jong","year":"2021","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.xkme.2025.101200_bib6","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jacc.2019.08.1031","article-title":"Anticoagulation in concomitant chronic kidney disease and atrial fibrillation: JACC review topic of the week","volume":"74","author":"Kumar","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.xkme.2025.101200_bib8","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.xkme.2025.101200_bib9","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.xkme.2025.101200_bib10","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMAi"},{"issue":"2","key":"10.1016\/j.xkme.2025.101200_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.xkme.2025.101200_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.xkme.2025.101200_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/clc.22435","article-title":"The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"38","author":"Zhu","year":"2015","journal-title":"Clin Cardiol"},{"issue":"11","key":"10.1016\/j.xkme.2025.101200_bib15","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/europace\/euac096","article-title":"Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation","volume":"24","author":"van der Endt","year":"2022","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.xkme.2025.101200_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/europace\/euz358","volume":"22","author":"Potpara","year":"2020","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.xkme.2025.101200_bib17","first-page":"924","article-title":"Anticoagulation for patients with atrial fibrillation and end-stage renal disease on dialysis: a national survey","volume":"37","author":"Halperin","year":"2021","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: what, why, how, when and where?","volume":"14","author":"Ramspek","year":"2021","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.xkme.2025.101200_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1681\/ASN.2021060744","article-title":"Management of adults with newly diagnosed atrial fibrillation with and without CKD","volume":"33","author":"Bansal","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2025.101200_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.xkme.2025.101200_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.xkme.2025.101200_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.xkme.2025.101200_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jclinepi.2020.03.015","article-title":"A systematic review and external validation of stroke prediction models demonstrates poor performance in dialysis patients","volume":"123","author":"de Jong","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.xkme.2025.101200_bib24","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/ndt\/gfz018","article-title":"Towards the best kidney failure prediction tool: a systematic review and selection aid","volume":"35","author":"Ramspek","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.xkme.2025.101200_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jclinepi.2023.04.012","article-title":"Systematic metareview of prediction studies demonstrates stable trends in bias and low PROBAST inter-rater agreement","volume":"159","author":"Langenhuijsen","year":"2023","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"10.1016\/j.xkme.2025.101200_bib26","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models: users' guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib27","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.xkme.2025.101200_bib28","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/sim.791","article-title":"On tests of the overall treatment effect in meta-analysis with normally distributed responses","volume":"20","author":"Hartung","year":"2001","journal-title":"Stat Med"},{"issue":"21","key":"10.1016\/j.xkme.2025.101200_bib29","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/sim.1262","article-title":"A simple confidence interval for meta-analysis","volume":"21","author":"Sidik","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.xkme.2025.101200_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"10.1016\/j.xkme.2025.101200_bib31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/ndt\/gfy387","article-title":"Performance of bleeding risk scores in dialysis patients","volume":"34","author":"Ocak","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2025.101200_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"issue":"3","key":"10.1016\/j.xkme.2025.101200_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.hlc.2015.08.012","article-title":"Relationships between anticoagulation, risk scores and adverse outcomes in dialysis patients with atrial fibrillation","volume":"25","author":"Wang","year":"2016","journal-title":"Heart Lung Circ"},{"issue":"10","key":"10.1016\/j.xkme.2025.101200_bib34","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2025.101200_bib35","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.hrthm.2014.06.021","article-title":"Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis","volume":"11","author":"Chao","year":"2014","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.xkme.2025.101200_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ckj\/sfv006","article-title":"Advanced chronic kidney disease in non-valvular atrial fibrillation: extending the utility of R2CHADS2 to patients with advanced renal failure","volume":"8","author":"Bautista","year":"2015","journal-title":"Clin Kidney J"},{"issue":"46","key":"10.1016\/j.xkme.2025.101200_bib37","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1093\/eurheartj\/eht328","article-title":"Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial","volume":"34","author":"Apostolakis","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.xkme.2025.101200_bib38","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jjcc.2014.03.006","article-title":"Improvement of HAS-BLED bleeding score predictive capability by changing the definition of renal dysfunction in Japanese atrial fibrillation patients on anticoagulation therapy","volume":"64","author":"Suzuki","year":"2014","journal-title":"J Cardiol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib39","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/eurheartj\/ehu139","article-title":"Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study","volume":"36","author":"Friberg","year":"2015","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1160\/TH13-01-0054","article-title":"Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?","volume":"109","author":"Roldan","year":"2013","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12882-021-02384-0","article-title":"Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation","volume":"22","author":"Bel-Ange","year":"2021","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.xkme.2025.101200_bib42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s40620-016-0364-8","article-title":"Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study","volume":"30","author":"Genovesi","year":"2017","journal-title":"J Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101200_bib43","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/1744-9987.12460","article-title":"Cardiovascular and stroke risk in Japanese hemodialysis patients with atrial fibrillation","volume":"20","author":"Hasegawa","year":"2016","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.xkme.2025.101200_bib44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.115.018294","article-title":"Risks of death and stroke in patients undergoing hemodialysis with new-onset atrial fibrillation: a competing-risk analysis of a nationwide cohort","volume":"133","author":"Shih","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.xkme.2025.101200_bib45","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ki.2013.170","article-title":"Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS","volume":"84","author":"Sood","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2025.101200_bib46","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s10157-013-0885-6","article-title":"Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study","volume":"18","author":"Wakasugi","year":"2014","journal-title":"Clin Exp Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2025.101200_bib47","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.xkme.2025.101200_bib48","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/JCMA.0000000000000417","article-title":"Risk of ischemic stroke in patients with end-stage renal disease receiving peritoneal dialysis with new-onset atrial fibrillation","volume":"83","author":"Lee","year":"2020","journal-title":"J Chin Med Assoc"},{"issue":"11","key":"10.1016\/j.xkme.2025.101200_bib49","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/CIRCULATIONAHA.113.004777","article-title":"Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis","volume":"129","author":"Shah","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib50","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10557-020-07108-4","article-title":"Effectiveness and safety of direct oral anticoagulants in an Asian population with atrial fibrillation undergoing dialysis: a population-based cohort study and meta-analysis","volume":"35","author":"See","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"10.1016\/j.xkme.2025.101200_bib51","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000521494","article-title":"Warfarin use, stroke, and bleeding risk among pre-existing atrial fibrillation US veterans transitioning to dialysis","volume":"146","author":"Sy","year":"2022","journal-title":"Nephron"},{"issue":"8","key":"10.1016\/j.xkme.2025.101200_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1159\/000508836","article-title":"Assessment of the CHA2DS2-VASc score in predicting mortality and adverse cardiovascular outcomes of patients on hemodialysis","volume":"51","author":"Schamroth Pravda","year":"2020","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib53","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/europace\/euv289","article-title":"Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis","volume":"18","author":"Chan","year":"2016","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.xkme.2025.101200_bib54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.annepidem.2012.12.011","article-title":"Atrial fibrillation and risk of stroke in dialysis patients","volume":"23","author":"Wetmore","year":"2013","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ckj\/sfaa146","article-title":"Same rhythm, different song-approaches to atrial fibrillation management by cardiologists and nephrologists","volume":"14","author":"Mark","year":"2021","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1016\/j.xkme.2025.101200_bib56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCULATIONAHA.112.107128","volume":"127","author":"Piccini","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.xkme.2025.101200_bib57","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.xkme.2025.101200_bib58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jclinepi.2021.06.017","article-title":"Large-scale validation of the prediction model risk of bias assessment Tool (PROBAST) using a short form: high risk of bias models show poorer discrimination","volume":"138","author":"Venema","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib59","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3390\/jcm12051976","article-title":"Inter-rater agreement in assessing risk of bias in melanoma prediction studies using the prediction model risk of bias assessment tool (PROBAST): results from a controlled experiment on the effect of specific rater training","volume":"12","author":"Kaiser","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xkme.2025.101200_bib60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I(2) in assessing heterogeneity may mislead","volume":"8","author":"R\u00fccker","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib62","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCEP.113.000869","article-title":"Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry","volume":"6","author":"Kornej","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101200_bib63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2025.101200_bib64","first-page":"1180","article-title":"Renal function and outcome of patients with non-valvular atrial fibrillation","volume":"10","author":"Barashi","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.xkme.2025.101200_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.amjcard.2023.03.018","article-title":"Comparison of stroke and bleeding risk profile in patients with atrial fibrillation and chronic kidney disease","volume":"196","author":"Parada Barcia","year":"2023","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib66","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1038\/s41598-022-10164-5","article-title":"Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status","volume":"12","author":"Calderon","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.xkme.2025.101200_bib67","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.05.007","article-title":"Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease","volume":"21","author":"Eikelboom","year":"2012","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"11","key":"10.1016\/j.xkme.2025.101200_bib68","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2215\/CJN.02400311","article-title":"Warfarin in atrial fibrillation patients with moderate chronic kidney disease","volume":"6","author":"Hart","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101200_bib69","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/ehjqcco\/qcac069","article-title":"Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study","volume":"9","author":"Jun","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.xkme.2025.101200_bib70","article-title":"Direct oral anti-Xa anticoagulants versus warfarin in newly diagnosed atrial fibrillation and CKD: the Korean National Health Insurance Data","volume":"10","author":"Kee","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"10.1016\/j.xkme.2025.101200_bib71","first-page":"867","article-title":"Chronic kidney disease and risks of adverse clinical events in patients with atrial fibrillation","volume":"18","author":"Li","year":"2021","journal-title":"J Geriatr Cardiol"},{"issue":"2","key":"10.1016\/j.xkme.2025.101200_bib72","first-page":"243","article-title":"Are existing risk scores for nonvalvular atrial fibrillation useful for prediction or risk adjustment in patients with chronic kidney disease?","volume":"33","author":"McAlister","year":"2017","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.xkme.2025.101200_bib73","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjcard.2010.10.074","article-title":"Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation","volume":"107","author":"Nakagawa","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.xkme.2025.101200_bib74","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjcard.2023.06.105","article-title":"Adverse clinical outcomes and associated predictors in rivaroxaban-treated atrial fibrillation patients with renal impairment","volume":"203","author":"Rivera-Caravaca","year":"2023","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101104","article-title":"Warfarin Usage in patients with atrial fibrillation undergoing hemodialysis in Indonesian population","volume":"48","author":"Akbar","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.xkme.2025.101200_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847286","article-title":"Direct oral anticoagulants vs. warfarin in hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis","volume":"9","author":"Elfar","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.xkme.2025.101200_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40620-013-0030-3","article-title":"The nephrologist\u2019s anticoagulation treatment patterns\/regimens in chronic hemodialysis patients with atrial fibrillation","volume":"27","author":"Genovesi","year":"2014","journal-title":"J Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/medicina58010058","article-title":"Survival benefit of anticoagulation therapy in end stage kidney disease patients with atrial fibrillation: a single center retrospective study","volume":"58","author":"Kim","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"23","key":"10.1016\/j.xkme.2025.101200_bib79","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.xkme.2025.101200_bib80","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A randomized controlled trial comparing apixaban with the vitamin K antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study","volume":"147","author":"Reinecke","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib81","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/j.ajkd.2022.03.007","article-title":"Apixaban dosing patterns versus warfarin in patients with nonvalvular atrial fibrillation receiving dialysis: a retrospective cohort study","volume":"80","author":"Wetmore","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2025.101200_bib82","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/imj.15605","article-title":"Benefit and harm of anticoagulation in the prevention of thromboembolic stroke for non-valvular atrial fibrillation in haemodialysis patients - a Top End of Northern Australia study","volume":"53","author":"Xu","year":"2023","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.xkme.2025.101200_bib83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3349\/ymj.2022.0455","article-title":"Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF Registry","volume":"64","author":"Park","year":"2023","journal-title":"Yonsei Med J"},{"issue":"5","key":"10.1016\/j.xkme.2025.101200_bib84","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ckj\/sfad004","article-title":"Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D","volume":"16","author":"Welander","year":"2023","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1016\/j.xkme.2025.101200_bib85","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ckj\/sfac022","article-title":"Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D","volume":"15","author":"Welander","year":"2022","journal-title":"Clin Kidney J"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525002365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525002365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:51:32Z","timestamp":1778907092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525002365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2590059525002365"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101200","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review and Meta-analysis of the Predictive Performance of Stroke and Bleeding Prediction Models in Atrial Fibrillation Patients With Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101200"}}